Telmisartan Market, By Composition (Single and Combinational), By Indication (Hypertension, Nephropathy, Hepatorenal Syndrome, Cardiac Arrest, Stroke), By Dosage Form (Tablets, Capsules, Injection, Oral suspension), By Distribution Channel (Hospital Pharm

Telmisartan Market, By Composition (Single and Combinational), By Indication (Hypertension, Nephropathy, Hepatorenal Syndrome, Cardiac Arrest, Stroke), By Dosage Form (Tablets, Capsules, Injection, Oral suspension), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)


Telmisartan is an angiotensin II receptor antagonist that is used primarily in the treatment of hypertension and diabetic nephropathy. It works by selectively blocking the binding of angiotensin II to the AT1 receptors present in vascular smooth muscle and the adrenal glands. By blocking the vasoconstrictor and aldosterone-secreting effects of angiotensin II, telmisartan helps lower blood pressure. It is available under various brand names as an oral medication and has a well-established safety profile supported by long-term clinical trials. Growing awareness about cardiovascular health and increasing prevalence of hypertension can drive the global telmisartan market growth.

Market Dynamics:

Global telmisartan market growth is driven by factors such as rapidly aging population, rising prevalence of hypertension worldwide, increasing adoption of sedentary lifestyle resulting in obesity, and growing healthcare expenditure in emerging nations. However, availability of generic substitutes and patent expiration of major brands can pose challenges for market players. Continuous research on expanding therapeutic applications of telmisartan and ongoing clinical trials evaluating its efficacy in treatment of conditions beyond hypertension can offer opportunities for stakeholders in the near future. Partnerships with local distribution networks in developing countries also provide an attractive avenue for leveraging unmet demand.

Key Features of the Study:
  • This report provides in-depth analysis of the global telmisartan market, and provides market size (US$ Billion) and compound annual growth rate (CAGR%) for the forecast period (2024–2031), considering 2023 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the global telmisartan market based on the following parameters – company highlights, products portfolio, key highlights, financial performance, and strategies
  • Key companies covered as a part of this study include, Boehringer Ingelheim GmbH, Glenmark Pharmaceuticals Ltd., Teva Pharmaceutical Industries Ltd., Sandoz International GmbH, Aurobindo Pharma, Sun Pharmaceutical Industries Ltd., Mylan N.V., Cipla Ltd., Abbott Laboratories, Cadila Healthcare Ltd, Torrent Pharmaceuticals Ltd., Merck KGaA, Pfizer Inc., Sanofi S.A., Bayer AG, AstraZeneca PLC, Daiichi Sankyo Company, Limited, Macleods Pharmaceuticals Ltd.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
  • Global telmisartan market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global telmisartan market
Detailed Segmentation-
  • By Composition
  • Single
  • Combinational
  • By Indication
  • Hypertension
  • Nephropathy
  • Hepatorenal Syndrome
  • Cardiac Arrest
  • Stroke
  • By Dosage Form
  • Tablets
  • Capsules
  • Injection
  • Oral suspension
  • By Distribution Channel
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
  • By Region
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East
  • Africa
  • Company Profiles:
  • Boehringer Ingelheim GmbH
  • Glenmark Pharmaceuticals Ltd.
  • Teva Pharmaceutical Industries Ltd.
  • Sandoz International GmbH
  • Aurobindo Pharma
  • Sun Pharmaceutical Industries Ltd.
  • Mylan N.V.
  • Cipla Ltd.
  • Abbott Laboratories
  • Cadila Healthcare Ltd
  • Torrent Pharmaceuticals Ltd.
  • Merck KGaA
  • Pfizer Inc.
  • Sanofi S.A.
  • Bayer AG
  • AstraZeneca PLC
  • Daiichi Sankyo Company, Limited
  • Macleods Pharmaceuticals Ltd.


1. Research Objectives and Assumptions
Research Objectives
Assumptions
Abbreviations
2. Market Purview
Report Description
Market Definition and Scope
Executive Summary
Market Snapshot, By Composition
Market Snapshot, By Indication
Market Snapshot, By Dosage Form
Market Snapshot, By Distribution Channel
Market Snapshot, By Region
Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
Market Dynamics
Drivers
Restraints
Opportunities
Impact Analysis
Market Trends
Key Developments
Regulatory Scenario
Acquisitions and Partnerships Scenario
Funding and Investments
PEST Analysis
Porter’s Analysis
4. Global Telmisartan Market - Impact of Coronavirus (COVID-19) Pandemic
Overall Impact
Government Initiatives
COVID-19 Impact on the Market
5. Global Telmisartan Market, By Composition, 2019 – 2031, (USD Bn)
Overview
Market Share Analysis, 2024 and 2031 (%)
Y-o-Y Growth Analysis, 2019 – 2031
Segment Trends
Single
Overview
Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD Bn)
Combinational
Overview
Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD Bn)
6. Global Telmisartan Market, By Indication 2019 – 2031, (USD Bn)
Overview
Market Share Analysis, 2024 and 2031 (%)
Y-o-Y Growth Analysis, 2019 – 2031
Segment Trends
Hypertension
Overview
Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD Bn)
Nephropathy
Overview
Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD Bn)
Hepatorenal Syndrome
Overview
Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD Bn)
Cardiac Arrest
Overview
Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD Bn)
Stroke
Overview
Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD Bn)
7. Global Telmisartan Market, By Dosage Form, 2019 – 2031, (USD Bn)
Overview
Market Share Analysis, 2024 and 2031 (%)
Y-o-Y Growth Analysis, 2019 – 2031
Segment Trends
Tablets
Overview
Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD Bn)
Capsules
Overview
Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD Bn)
Injection
Overview
Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD Bn)
Oral suspension
Overview
Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD Bn)
8. Global Telmisartan Market, By Distribution Channel 2019 – 2031, (USD Bn)
Overview
Market Share Analysis, 2024 and 2031 (%)
Y-o-Y Growth Analysis, 2019 – 2031
Segment Trends
Hospital Pharmacies
Overview
Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD Bn)
Retail Pharmacies
Overview
Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD Bn)
Online Pharmacies
Overview
Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD Bn)
9. Global Telmisartan Market, By Region, 2019 – 2031, (USD Bn)
Introduction
Market Share Analysis, By Region, 2024 and 2031 (%)
Y-o-Y Growth Analysis, For Region, 2019–2031
Regional Trends
North America
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Composition, 2019 - 2031, (USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By Indication, 2019 - 2031, (USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By Dosage Form 2019 - 2031, (USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 – 2031, (USD Bn)
U.S.
Canada
Latin America
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Composition, 2019 - 2031, (USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By Indication, 2019 - 2031, (USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By Dosage Form 2019 - 2031, (USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 – 2031, (USD Bn)
Brazil
Mexico
Argentina
Rest of Latin America
Europe
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Composition, 2019 - 2031, (USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By Indication, 2019 - 2031, (USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By Dosage Form 2019 - 2031, (USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 – 2031, (USD Bn)
U.K.
Germany
Italy
France
Spain
Russia
Rest of Europe
Asia Pacific
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Composition, 2019 - 2031, (USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By Indication, 2019 - 2031, (USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By Dosage Form 2019 - 2031, (USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 – 2031, (USD Bn)
China
India
Japan
ASEAN
Australia
South Korea
Rest of Asia Pacific
Middle East
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Composition, 2019 - 2031, (USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By Indication, 2019 - 2031, (USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By Dosage Form 2019 - 2031, (USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 – 2031, (USD Bn)
GCC Countries
Israel
Rest of Middle East
Africa
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Composition, 2019 - 2031, (USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By Indication, 2019 - 2031, (USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By Dosage Form 2019 - 2031, (USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2019 – 2031, (USD Bn)
North Africa
Central Africa
South Africa
10. Competitive Landscape
Company Profiles
Boehringer Ingelheim GmbH
Company Highlights
Composition Portfolio
Key Highlights
Financial Performance
Market Strategies
Glenmark Pharmaceuticals Ltd.
Company Highlights
Composition Portfolio
Key Highlights
Financial Performance
Market Strategies
Teva Pharmaceutical Industries Ltd.
Company Highlights
Composition Portfolio
Key Highlights
Financial Performance
Market Strategies
Sandoz International GmbH
Company Highlights
Composition Portfolio
Key Highlights
Financial Performance
Market Strategies
Aurobindo Pharma
Sun Pharmaceutical Industries Ltd.
Mylan N.V.
Cipla Ltd.
Abbott Laboratories
Cadila Healthcare Ltd
Torrent Pharmaceuticals Ltd.
Merck KGaA
Pfizer Inc.
Sanofi S.A.
Bayer AG
AstraZeneca PLC
Daiichi Sankyo Company, Limited
Macleods Pharmaceuticals Ltd.
11. Analyst Recommendations
Wheel of Fortune
Analyst View
Coherent Opportunity Map
12. References and Research Methodology
References
Research Methodology
About us and Sales Contact
*Browse 32 market data tables and 28 figures on Telmisartan Market” - Global forecast to 2031

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings